These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 1644256)

  • 1. Glucose and diabetic vascular disease.
    Ruderman NB; Williamson JR; Brownlee M
    FASEB J; 1992 Aug; 6(11):2905-14. PubMed ID: 1644256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperglycemia and microangiopathy. Direct regulation by glucose of microvascular cells.
    Kreisberg JI
    Lab Invest; 1992 Oct; 67(4):416-26. PubMed ID: 1434526
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of protein kinase C activation and the vascular complications of diabetes.
    Das Evcimen N; King GL
    Pharmacol Res; 2007 Jun; 55(6):498-510. PubMed ID: 17574431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemistry and molecular cell biology of diabetic complications.
    Brownlee M
    Nature; 2001 Dec; 414(6865):813-20. PubMed ID: 11742414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical and molecular mechanisms in the development of diabetic vascular complications.
    King GL; Kunisaki M; Nishio Y; Inoguchi T; Shiba T; Xia P
    Diabetes; 1996 Jul; 45 Suppl 3():S105-8. PubMed ID: 8674872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cellular and molecular mechanisms of diabetic complications.
    King GL; Brownlee M
    Endocrinol Metab Clin North Am; 1996 Jun; 25(2):255-70. PubMed ID: 8799700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The missing link: a single unifying mechanism for diabetic complications.
    Nishikawa T; Edelstein D; Brownlee M
    Kidney Int Suppl; 2000 Sep; 77():S26-30. PubMed ID: 10997687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High glucose-induced activation of protein kinase signaling pathways in vascular smooth muscle cells: a potential role in the pathogenesis of vascular dysfunction in diabetes (review).
    Srivastava AK
    Int J Mol Med; 2002 Jan; 9(1):85-9. PubMed ID: 11745003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preventive treatment of diabetic microangiopathy: blocking the pathogenic mechanisms].
    Guillausseau PJ
    Diabete Metab; 1994; 20(2 Pt 2):219-28. PubMed ID: 8001709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New theories of the pathogenesis of diabetic neuropathies].
    Lekishvili VP
    Klin Med (Mosk); 1974 Nov; 52(11):14-6. PubMed ID: 4373612
    [No Abstract]   [Full Text] [Related]  

  • 11. Activation of protein kinase C by elevation of glucose concentration: proposal for a mechanism in the development of diabetic vascular complications.
    Lee TS; Saltsman KA; Ohashi H; King GL
    Proc Natl Acad Sci U S A; 1989 Jul; 86(13):5141-5. PubMed ID: 2740348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular system disease in youth patients with various forms of glucose metabolism impairment - diagnosis and treatment.
    Otto-Buczkowska E; Dworzecki T; Mazur-Dworzecka U
    Pediatr Endocrinol Diabetes Metab; 2008; 14(1):31-5. PubMed ID: 18577344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of hyperglycemia in the development of diabetic microangiopathy].
    Miyata S; Kasuga M
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():45-51. PubMed ID: 15999684
    [No Abstract]   [Full Text] [Related]  

  • 14. Post-prandial hyperglycemia and microvascular complications.
    Dhanwal D; Tandon N
    J Assoc Physicians India; 2001 Jan; 49 Spec No():28-31. PubMed ID: 11235602
    [No Abstract]   [Full Text] [Related]  

  • 15. [Erythrocyte sorbitol, sorbitol dehydrogenase (SDH), and glyceraldehyde reductase (GAR) in diabetes mellitus].
    Hosojima H
    Nihon Rinsho; 2002 Aug; 60 Suppl 8():486-91. PubMed ID: 12355795
    [No Abstract]   [Full Text] [Related]  

  • 16. [Sorbitol route of glucose metabolism and complication of diabetes mellitus].
    Efimov AS; Skrobonskaia NA; Petakh NN
    Probl Endokrinol (Mosk); 1980; 26(3):86-90. PubMed ID: 6773043
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of hyperglycemia and hyperinsulinemia in the pathogenesis of diabetic angiopathy.
    Haller H; Drab M; Luft FC
    Clin Nephrol; 1996 Oct; 46(4):246-55. PubMed ID: 8905209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the sphingosine kinase-signaling pathway by high glucose mediates the proinflammatory phenotype of endothelial cells.
    Wang L; Xing XP; Holmes A; Wadham C; Gamble JR; Vadas MA; Xia P
    Circ Res; 2005 Oct; 97(9):891-9. PubMed ID: 16179586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycosylation of proteins and microangiopathy.
    Brownlee M
    Hosp Pract (Off Ed); 1992 Feb; 27 Suppl 1():46-50. PubMed ID: 1347540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diabetic nephroangiopathy and its treatment].
    Perelygina AA; Kasymova SD; Alekseev IuP
    Sov Med; 1980; (3):66-71. PubMed ID: 6990518
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.